{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:22:03Z","timestamp":1789744923459,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ygyno.2013.10.018","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T14:02:54Z","timestamp":1382450574000},"page":"93-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["HDR brachytherapy for the reirradiation of cervical and vaginal cancer: Analysis of efficacy and dosage delivered to organs at risk"],"prefix":"10.1016","volume":"132","author":[{"given":"Agnieszka","family":"Zolciak-Siwinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Bijok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jonska-Gmyrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kawczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucyna","family":"Kepka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Bujko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.10.018_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.radonc.2010.04.015","article-title":"MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy","volume":"96","author":"Haie-Meder","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.04.012","article-title":"Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer","volume":"83","author":"P\u00f6tter","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2009.07.001","article-title":"Dose\u2013effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy","volume":"93","author":"Dimopoulos","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijrobp.2008.10.033","article-title":"Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy","volume":"75","author":"Dimopoulos","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0025","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.ygyno.2008.05.024","article-title":"Surgical treatment of recurrent cervical cancer: state of the art and new achievements","volume":"110","author":"Chiva","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2005.10.011","article-title":"Total pelvic exenteration: the Albert Einstein College of Medicine Montefiore Medical Center Experience (1987 to 2003)","volume":"101","author":"Goldberg","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2005.05.034","article-title":"Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA","volume":"99","author":"Berek","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/00015458.2011.11680754","article-title":"Pelvic exenteration: long-term oncological results in a series of 106 patients","volume":"111","author":"De Wever","year":"2011","journal-title":"Acta Chir Belg"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0045","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/IGC.0b013e31824eb8cd","article-title":"Pelvic exenterations for gynecological malignancies: a study of 36 cases","volume":"22","author":"Kaur","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2009.09.035","article-title":"Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? A twenty-year experience","volume":"116","author":"Jurado","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000296300","article-title":"The role of exenterative surgery and urinary diversion in persistent or locally recurrent gynecological malignancy: complications and survival","volume":"85","author":"Spahn","year":"2010","journal-title":"Urol Int"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0360-3016(01)01507-3","article-title":"Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers","volume":"50","author":"Gemignani","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11864-002-0056-6","article-title":"Recurrent cervical cancer","volume":"3","author":"Leitao","year":"2002","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/gyno.1993.1005","article-title":"Interstitial reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors","volume":"48","author":"Randall","year":"1993","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/0973-1482.48766","article-title":"Reirradiation with high-dose-rate remote afterloading brachytherapy implant in patients with locally recurrent or residual cervical carcinoma","volume":"5","author":"Badakh","year":"2009","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00066-006-1420-4","article-title":"Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma","volume":"182","author":"Weitmann","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0085","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0360-3016(95)02137-X","article-title":"Phase III Study of interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: a prospectively controlled randomized study by the Radiation Therapy Oncology Group","volume":"34","author":"Emami","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.radonc.2009.12.004","article-title":"Stereotactic body radiotherapy for boost irradiation in unfavourable locally recurrent gynaecological cancer","volume":"94","author":"Guckenberger","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0095","series-title":"Dose and volume specification for reporting intracavitary therapy in gynecology","year":"1985"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0105","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0360-3016(95)00057-6","article-title":"Overview late effects of normal tissues (LENT) scoring system","volume":"31","author":"Rubin","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2011.03.010","article-title":"Second re-irradiation: efficacy, dose and toxicity in patients who received three courses of radiotherapy with overlapping fields","volume":"99","author":"Abusaris","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/S1053-4296(00)80039-9","article-title":"Clinical experience with retreatment for palliation","volume":"10","author":"Morris","year":"2000","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0125","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.semradonc.2008.04.004","article-title":"The linear-quadratic model is a appropriate methodology for determining isoeffective doses at large doses per fraction","volume":"18","author":"Brenner","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/(SICI)1097-0215(19980821)79:4<365::AID-IJC10>3.0.CO;2-4","article-title":"Tumor hypoxia in pelvic recurrences of cervical cancer","volume":"79","author":"H\u00f6ckel","year":"1998","journal-title":"Int J Cancer (Pred Oncol)"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0135","first-page":"CD006377","article-title":"Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma","volume":"17","author":"Lutgens","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ygyno.2013.10.018_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2013.04.011","article-title":"HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy\u2014a phase III study","author":"Zolciak-Siwinska","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813012675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813012675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T02:43:36Z","timestamp":1564541016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813012675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0090825813012675"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDR brachytherapy for the reirradiation of cervical and vaginal cancer: Analysis of efficacy and dosage delivered to organs at risk","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}